Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

143
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
143

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Challenging Weight-Tiered Antibiotic Prophylaxis in Obese Patients Undergoing Colorectal Surgery Using CT-Derived Body Composition.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

The effects of neoadjuvant chemoradiotherapy-related frailty by analytic morphomics in esophageal cancer.

Journal of cardiothoracic surgery·2026
Same author

Name MASLD/MASH - and act on it.

JHEP reports : innovation in hepatology·2026
Same author

Practice changing RCT design and rationale: Abbreviated MRI plus AFP <i>vs.</i> ultrasound plus AFP for HCC surveillance in cirrhosis (PREMIUM study).

JHEP reports : innovation in hepatology·2026
Same author

Name MASLD/MASH - and act on it.

Annals of hepatology·2026
Same author

Name MASLD/MASH - and act on it.

Hepatology communications·2026

相关实验视频

Updated: Jul 23, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K

使用人工智能从计算机断层扫描扫描中预测肝硬化

Nikhilesh R Mazumder1,2, Binu Enchakalody3, Peng Zhang3

  • 1Gastroenterology Section, VA Ann Arbor Healthcare System, Ann Arbor, Michigan, USA.

Clinical and translational gastroenterology
|July 12, 2023
PubMed
概括

使用CT扫描和患者数据的自动化工具可以预测肝硬化,改善移植前和移植后患者的检测. 这有助于更有效地诊断肝病.

更多相关视频

Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI
06:09

Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI

Published on: July 21, 2023

1.2K
Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

1.2K

相关实验视频

Last Updated: Jul 23, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K
Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI
06:09

Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI

Published on: July 21, 2023

1.2K
Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

1.2K

科学领域:

  • 放射学和医学成像学 医学成像学
  • 肝病学 肝病学是一种肝病学.
  • 人工智能在医学中的应用

背景情况:

  • 未诊断的肝硬化是一个重大的临床挑战.
  • 准确预测肝硬化对于患者的管理和治疗至关重要.
  • 现有的诊断方法在某些患者群体中可能存在局限性.

研究的目的:

  • 开发和验证用于肝硬化预测的自动化肝脏细分工具.
  • 评估从CT扫描中提取的成像特征的性能.
  • 评估成像特征与临床数据的结合,以提高诊断准确度.

主要方法:

  • 在1590个CT扫描中训练了一种自动化肝脏细分模型 (3D-U-Net,DeeplLabv3+).
  • 从351名患者的外部队列中提取了CT和肝脏活检数据的成像特征.
  • 开发了使用梯度增强决策树的多变量模型来预测组织学性肝硬化.
  • 使用5倍交叉验证和接收操作特征 (aUC) 下的面积来评估模型性能.

主要成果:

  • 肝脏形态与实验室和人口统计数据的结合实现了0.85 (0.81-0.90) 的aUC.
  • 这种组合模型的表现明显超过单独的FIB-4 (aUC 0.76) (P < 0.001).
  • 仅仅肝脏形态学就显示了与FIB-4 (aUC 0.71 与 0.76) 相比的性能.

结论:

  • 自动提取的CT特征与电子医疗记录数据相结合,改善了肝硬化预测.
  • 这种工具显示出在移植前和移植后患者中检测未被诊断的肝硬化症的潜力.
  • 这项原则证明研究突出了肝病管理的有希望的方法.